Breast Cancer
A Randomized Double Blind Placebo-Controlled Trial of Neratinib (HKI-272) Following Trastuzumab in Women With Early-Stage HER-2/neu Overexpressed/Amplified Breast Cancer
Trial ID: 08201
Contact: Sharon S Ambro
Phone: (972)841-8345
Learn More about this trial.
go back | new search